Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: J Neuroimmunol. 2018 Mar 17;319:80–92. doi: 10.1016/j.jneuroim.2018.03.009

Fig. 9.

Fig. 9

GM-CSF increases expression of calbindin and synaptophysin in AD mice. (A, B) Expression of calbindin (A) and synaptophysin (B) was determined in the dentate gyrus (DG) of the hippocampus for non-Tg and AD mice treated with PBS or GM-CSF. Scale bar = 200 μm for primary figures and 50 μm for insets (C, D). Quantification of calbindin (C) and synaptophysin (D) expression levels (n = 8 per group, 12 sections per brain). Data represent mean fluorescence intensity ± SEM and p ≤ 0.05 compared to anon-Tg/PBS, bnon-Tg/GM-CSF, or dAD/GM-CSF as determined by one-way ANOVA and Newman-Keuls post-hoc test.